-
Cabozantinib (XL184) for Adaptive Signaling Studies
2026-08-24
Use Cabozantinib (XL184) to connect RTK inhibition with angiogenesis, phosphoproteomic remodeling, and motility in cancer models. This workflow emphasizes exposure timescale, site-specific MET interpretation, and assay controls that distinguish cytostasis from adaptive invasion.
-
Rhodamine 123: A Transporter-Context Assay Guide
2026-08-23
Rhodamine 123 (chloride) is more than a fluorescent P-glycoprotein substrate: its signal reflects coordinated uptake, efflux, sequestration, and metabolism. This guide presents a context-aware strategy for interpreting live-cell transport data and connecting ABCB1/MDR1 assays with contemporary ABC transporter research.
-
Imeglimin and Mitochondria in Carpal Tunnel Syndrome
2026-08-22
The reference study examined whether imeglimin could improve mitochondrial dysfunction in subsynovial connective-tissue cells from patients with idiopathic carpal tunnel syndrome. Its integrated analysis links cellular viability, redox balance, mitochondrial structure, gene expression, and permeability-transition biology, while also defining important limits for translating ex vivo findings into mitochondrial or clinical therapy.
-
Oridonin Targets Inflammation in Esophageal Cancer
2026-08-22
Peng et al. use a 4-NQO-induced murine model to connect oridonin treatment with reduced esophageal inflammation and suppression of TLR4/NF-κB/NLRP3 inflammasome-associated signaling. The study’s value is its integrated histologic, hematologic, cytokine, transcript, and protein readouts, while its preclinical design still leaves pathway causality and clinical transferability unresolved.
-
Lyso-Tracker Red for Live-Cell Lysosome Assays
2026-08-21
Build reproducible live-cell lysosome assays with Lyso-Tracker Red, from nanomolar staining and fluorescence imaging to flow-cytometry readouts. The workflow also shows how lysosomal acidity measurements can clarify nanoparticle uptake and escape in dendritic-cell vaccine studies.
-
Bradford Protein Assay Kit: Practical Guide
2026-08-20
The Bradford Protein Assay Kit (SKU K4103) provides rapid protein concentration measurement from small liquid samples using Coomassie dye and BSA standards. It is suited to enzyme assays, protein purification, and molecular biology workflows, but samples with high detergent or other dye-binding interferents require cleanup or an alternative assay.
-
Valemetostat: Epigenetic Priming for CAR-T
2026-08-20
Valemetostat (DS-3201) is an EZH2-focused epigenetic cancer therapy with emerging relevance for lymphoma and adoptive T-cell research. This article explains how EZH1/EZH2 inhibition may remodel tumor immunogenicity and translates the 2025 Cancer Cell findings into practical assay decisions.
-
JXY Reprograms Macrophages in Colitis-Associated CRC
2026-08-19
Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in an orthotopic mouse model by shifting macrophages toward an M1-associated phenotype through TLR4-linked signaling. The study combines tumor pathology, macrophage phenotyping, gene-expression analysis, flow cytometry, and pharmacological pathway interrogation to connect immune-microenvironment remodeling with reduced tumor burden.
-
Biotin-tyramide: Designing Spatial Readouts
2026-08-19
Biotin-tyramide converts HRP activity into a localized biotin signal for sensitive IHC and ISH. This guide explains how to use the reagent as a spatial assay layer alongside chemoproteomic studies, including the SLC15A4 inhibitor work reported in Nature Chemical Biology.
-
Clathrin-Mediated Entry of Type III GCRV
2026-08-18
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through dynamin-dependent, clathrin-mediated endocytosis that requires endosomal acidification. The study also clarifies why IPA-3 is informative as a negative mechanistic probe in this antiviral-entry model rather than evidence of a Pak1-dependent uptake pathway.
-
Disodium Bicinchoninate: Aqueous Assay Reagent
2026-08-18
Disodium bicinchoninate is a water-soluble biquinoline dicarboxylate sodium salt for research workflows that require an aqueous soluble small molecule. The product record reports 368.32 g/mol molecular weight, 98.00% purity, and water solubility of at least 48.4 mg/mL, while the cited endothelial study provides biological context rather than direct evidence for this compound.
-
Dehydroabietic Acid: From PPARs to Ferroptosis
2026-08-17
Dehydroabietic acid is more than a dual PPAR-α/γ agonist: it can serve as a mechanistic perturbation tool for separating lipid metabolism regulation from glutamine-dependent ferroptosis resistance. This guide translates recent HCC findings into careful, hypothesis-driven assay design.
-
Biotin-tyramide TSA Workflows for RAB Mapping
2026-08-17
Biotin-tyramide converts localized HRP activity into durable biotin deposition for sensitive IHC, ISH, and spatial validation assays. This guide connects tyramide signal amplification with the RAB proximity-mapping strategy reported in Communications Biology, while emphasizing practical controls, optimization, and troubleshooting.
-
PDHA1 Succinylation and Immune Evasion in Cholangiocarcinoma
2026-08-16
The reference study defines a metabolic–immune mechanism in which PDHA1 succinylation at lysine 83 increases enzyme activity, promotes α-ketoglutarate accumulation, and suppresses macrophage MHC-II antigen presentation through OXGR1–MAPK signaling. Its findings connect tumor metabolic reprogramming with chemotherapy resistance and support further evaluation of succinylation-targeted combinations with gemcitabine and cisplatin.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-08-15
The reference study identifies O-GlcNAcylation as a critical metabolic effector of Wnt-stimulated osteogenesis. Its central mechanistic finding is that Wnt3a modifies PDK1 at Ser174, stabilizing this glycolytic regulator and linking Wnt signaling to glucose metabolism, bone formation, and fracture repair.